Urine Drug Test

Buprenorphine Rapid Test

Rapidly detect Buprenorphine in human urine with our easy-to-use test.

CE Certified
ISO 13485
Main image of Buprenorphine Rapid Test

Why Choose reOpenTest Toxicology & Drug Monitoring Kits?

Our tests are engineered for accuracy, reliability, and ease of use, ensuring confidence in every result.

Treatment Monitoring

Aids in monitoring patient compliance in MAT programs.

Quick Results

Get results in just 5-10 minutes.

Easy to Perform

Simple procedure for point-of-care testing.

Product Overview

The Buprenorphine Rapid Test is a qualitative immunoassay designed for the rapid detection of buprenorphine in human urine. This point-of-care test provides a convenient and efficient method for screening individuals for the presence of buprenorphine.

Technical Specifications

Detection Target Buprenorphine
Sample Type Urine
Methodology Immunochromatography
Detection Range Qualitative (Positive/Negative)
Reaction Time 5-10 minutes
Storage Conditions 2-30u00b0C
Shelf Life 18 months

Procedure & Interpretation

Step-by-Step Procedure

  1. Collect urine sample.
  2. Apply urine to the test device.
  3. Read results after 5-10 minutes.

Result Interpretation

Positive Result
Positive: Presence of buprenorphine detected.
Negative Result
Negative: No buprenorphine detected.
Invalid Result
Invalid: Test is invalid. Repeat with a new device.

Frequently Asked Questions

Buprenorphine is an opioid partial agonist used in medication-assisted treatment (MAT) for opioid use disorder.

This test helps healthcare professionals monitor patient compliance and assess the effectiveness of their treatment regimen.

Store at 2-30u00b0C.

Technical Documents

Download product inserts and brochures for detailed information.

No technical documents are available at this time. Please check back soon.

Partner with reOpenTest

Provide your clients and patients with reliable diagnostic solutions.
Contact us today for bulk pricing and distribution opportunities.

Become a Distributor